Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

People with androgenetic alopecia have more personality disorders and mental health symptoms; treatment may help.

Alopecia Areata causes emotional stress and stigma, but those with severe hair loss may adapt better.

People with hair loss feel more depressed and anxious, especially women, and need help managing emotions and beliefs about their condition.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Finasteride treatment in male rats causes long-lasting effects on depression-like behavior, brain cell growth, inflammation, and gut bacteria composition.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Minoxidil effectively treats female pattern hair loss.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

Skin diseases, especially psoriasis, greatly affect people's quality of life, similar to chronic diseases.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Tralokinumab for atopic dermatitis may cause side effects like dizziness, headache, nausea, hair loss, and acne.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

COVID-19 increased alopecia areata relapses due to inflammation and stress.